Drug Side Effects
Search
CUTANEOUS B-CELL LYMPHOMA
CUTANEOUS B-CELL LYMPHOMA
was reported 61 times
CUTANEOUS B-CELL LYMPHOMA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Antimetabolite Immunosuppressant [EPC]
5
0.0002
1
Sphingosine 1-phosphate Receptor Modulator [EPC]
3
0.0002
2
Antirheumatic Agent [EPC]
11
0.0001
3
Aminosalicylate [EPC]
9
0.0001
4
Folate Analog Metabolic Inhibitor [EPC]
24
0.0001
5
Alkylating Drug [EPC]
13
0.0001
6
CD20-directed Cytolytic Antibody [EPC]
10
0.0000
7
Interleukin-12 Antagonist [EPC]
3
0.0000
8
Interleukin-23 Antagonist [EPC]
3
0.0000
9
Topoisomerase Inhibitor [EPC]
2
0.0000
10
Calcineurin Inhibitor Immunosuppressant [EPC]
3
0.0000
11
Dietary Cholesterol Absorption Inhibitor [EPC]
2
0.0000
12
Prostaglandin Analog [EPC]
2
0.0000
13
Microtubule Inhibitor [EPC]
3
0.0000
14
Proteasome Inhibitor [EPC]
2
0.0000
15
Tumor Necrosis Factor Blocker [EPC]
17
0.0000
16
Corticosteroid [EPC]
19
0.0000
17
Platinum-based Drug [EPC]
4
0.0000
18
Tetracycline-class Drug [EPC]
1
0.0000
19
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
1
0.0000
20
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
21
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
22
Nucleoside Metabolic Inhibitor [EPC]
2
0.0000
23
Kinase Inhibitor [EPC]
3
0.0000
24
HMG-CoA Reductase Inhibitor [EPC]
2
0.0000
25
Thiazide Diuretic [EPC]
1
0.0000
26
Thalidomide Analog [EPC]
2
0.0000